Insider activity · ABBV · Healthcare

AbbVie Inc (ABBV) director adds stock-equivalent units after 25.5% 12-week rise

The insider acquisition lands with the biopharma stock still in an active weekly trend, though latest volume ran below its 13-week average.

AbbVie Inc
Latest259.36 USD
1W move1.9%
Volume0.7x
TrendActive
Biopharmaceutical laboratory and market-data screen representing AbbVie insider activity and weekly stock context.

Market update

What happened

AbbVie Inc (ABBV) recorded insider activity dated June 30, when Director Edward J. Rapp acquired 134 stock equivalent units at 251.64 USD per unit.

Weekly market data show the shares last closed at 259.36 USD, with a 1.9% one-week gain and a 3.1% four-week advance. The 52-week weekly price path remains constructive, supported by active trend status, Market Dynamics confirmation at 1.16, and Relative Strength of 9.3, while volume at 0.69 times the 13-week average tempers the signal.

Continue your research

Explore ABBV across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

ABBV coverage

Evidence context